FAP-FDG整合评分(FFIS):实体瘤双示踪剂PET表型的构建与预后验证
该回顾性研究纳入193例接受[18F]F-FDG与[68Ga]Ga-FAP-2286双PET/CT的实体瘤患者,构建整合代谢与间质信息的FFIS评分。FFIS在单因素(HR=1.79,P<0.001)和多因素(HR=1.75,P<0.001)分析中均为OS独立预测因子,评分越高生存越差,而FDG-SUVmax无独立预后价值。
要点
- FFIS整合FDG代谢与FAP间质信息,是实体瘤OS的独立预测因子。
- FFIS评分1无死亡,评分2、3、4中位OS分别为36、13、8个月。
- FDG-SUVmax无独立预后价值,FAP-SUVmax仅单因素分析有预测意义。
核心结论
- FFIS通过整合代谢与间质信息,在实体瘤中显示出初步预后价值。
研究设计与样本
- 回顾性研究纳入193例接受[18F]F-FDG和[68Ga]Ga-FAP-2286 PET/CT的实体瘤患者,以OS为主要终点。
- FFIS基于双示踪剂摄取强度与模式构建,采用Kaplan-Meier法及Cox比例风险模型评估预后价值。
主要发现
- FFIS在单因素分析(HR=1.79,P<0.001)和多因素分析(HR=1.75,P<0.001)中均为OS独立预测因子。
- FFIS评分1患者无死亡,评分2、3、4的中位OS分别为36、13、8个月(Log-Rank P<0.0001)。
- FFIS预后分层在几乎所有临床亚组中保持一致(P-interaction>0.05)。
- FDG-SUVmax无独立预后价值,FAP-SUVmax仅在单因素分析中有预测意义(HR=1.04,P=0.03)。
临床怎么用
- FFIS可用于实体瘤患者基于双示踪剂PET的预后风险分层,评分越高提示生存越差。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop a FAP-FDG integrated score (FFIS) based on [68Ga]Ga-FAP-2286 and [18F]F-FDG PET/CT, and evaluate its prognostic value for risk stratification compared to conventional single-parameter imaging. METHODS: This retrospective study included 193 patients with solid tumors who underwent both [18F]F-FDG and [68Ga]Ga-FAP-2286 PET/CT scans. Overall survival (OS) was the primary endpoint. The FFIS score was constructed by analyzing the uptake intensity and patterns of both radiotracers. Survival analysis employed the Kaplan-Meier method. The prognostic predictive value of FFIS, FDG-SUVmax, and FAP-SUVmax was evaluated using univariate and multivariate Cox proportional hazards models and compared with other clinical variables. Finally, subgroup analysis and interaction tests explored the prognostic consistency of FFIS, FDG-SUVmax, and FAP-SUVmax across different subgroups. RESULTS: FFIS emerged as an independent predictor of OS in both univariate (HR = 1.79, P < 0.001) and multivariate (HR = 1.75, P < 0.001) analyses. A higher FFIS reliably predicted worse survival: no deaths occurred among patients of score 1, whereas the median OS was 36, 13, and 8 months for scores 2, 3, and 4, respectively (Log-Rank P < 0.0001). This prognostic stratification remained consistent nearly all clinical subgroups (P-interaction > 0.05). In contrast, FDG-SUVmax showed no independent prognostic value, and FAP-SUVmax was predictive only in univariate analysis (HR = 1.04, P = 0.03). CONCLUSION: By integrating metabolic and stromal information, the FFIS may offer preliminary prognostic value across solid tumors.
引用
- Liu Y, Zhang T, Deng J, et al. The FAP-FDG Integration Score (FFIS): Development and prognostic validation of a dual-tracer PET phenotype for solid tumors. Eur J Nucl Med Mol Imaging. 2026. PMID: 42191945. doi:10.1007/s00259-026-07951-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。